Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    Study Finds How Cholesterol Drug Simvastatin Improves RA Inflammation
    July 13, 2016July 13, 2016

    Study Finds How Cholesterol Drug Simvastatin Improves RA Inflammation

    News
    Aarhus University researchers have discovered how simvastatin, a drug typically prescribed to reduce cholesterol, also leads to significant benefits in chronic inflammatory diseases such as rheumatoid arthritis, type 1 diabetes, and multiple ... Read more
    Rheumatoid Arthritis Effectively Diagnosed and Treated with Biodegradable Nanoparticles in Early Study
    July 11, 2016July 11, 2016

    Rheumatoid Arthritis Effectively Diagnosed and Treated with Biodegradable Nanoparticles in Early Study

    News
    Biodegradable polymer nanoparticles (BNPs), tiny particles made of a biodegradable polymer, appear to be quite useful for the early detection and for long-term, effective treatment of rheumatoid arthritis (RA) with minimal side effects, ... Read more
    Wondering Why RA Treatments Only Work on Certain Joints? DNA Methylation May Hold an Answer
    July 8, 2016July 8, 2016

    Wondering Why RA Treatments Only Work on Certain Joints? DNA Methylation May Hold an Answer

    News
    DNA methylation, a biological mechanism that controls which genes will be expressed and which ones will be silenced in different cells, varies between the cells lining the inside of different ... Read more
    Rheumatoid Arthritis: Insulin Resistance Might Affect How Well Anti-TNF Therapies Work
    July 1, 2016July 1, 2016

    Rheumatoid Arthritis: Insulin Resistance Might Affect How Well Anti-TNF Therapies Work

    News

    Insulin resistance seems to be directly associated with both oxidative stress and TNF-α levels in patients with rheumatoid arthritis (RA), according to a study conducted by Brazilian scientists.

    Read more
    Women With Rheumatoid Arthritis Have Higher Cardiovascular, Respiratory Disease-Related Mortality
    June 29, 2016June 29, 2016

    Women With Rheumatoid Arthritis Have Higher Cardiovascular, Respiratory Disease-Related Mortality

    News
    Women with rheumatoid arthritis (RA) have higher respiratory and cardiovascular disease-derived mortality than those without RA, according to a recent study. “Rheumatoid Arthritis and Mortality Among Women During 36 Years ... Read more
    There’s a Cellular Reason Why Rheumatoid Arthritis May Differ by Location, Researchers Say
    June 27, 2016June 27, 2016

    There’s a Cellular Reason Why Rheumatoid Arthritis May Differ by Location, Researchers Say

    News
    A team of researchers recently discovered that cellular differences in joints are linked to joint-specific differences in rheumatoid arthritis. Rheumatoid arthritis (RA) is a systemic inflammatory disease that manifests itself ... Read more
    Phase 3 Study Finds Oral Drug Reduces Joint Damage Caused by Rheumatoid Arthritis
    June 24, 2016June 24, 2016

    Phase 3 Study Finds Oral Drug Reduces Joint Damage Caused by Rheumatoid Arthritis

    News
    Once daily treatment of moderate to severe rheumatoid arthritis with the oral drug baricitinib significantly reduced structural damage to patients’ joints, according to a study presented at the recent EULAR Annual Congress in London. Data for ... Read more
    New Rheumatoid Arthritis Medication to Come Before FDA Advisory Committee
    June 20, 2016June 20, 2016

    New Rheumatoid Arthritis Medication to Come Before FDA Advisory Committee

    News
    The Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) will examine data supporting Amgen biotechnoloy company’s Biologics License Application (BLA) for ABP 501. The compound is a biosimilar candidate to Humira (adalimumab), ... Read more
    US Hospitalization Rates Show Decrease for Rheumatoid Arthritis, Increase for Gout
    June 17, 2016June 17, 2016

    US Hospitalization Rates Show Decrease for Rheumatoid Arthritis, Increase for Gout

    News
    Hospitalizations associated with gout show a dramatic increase in the past two decades in the United States, while those related to rheumatoid arthritis have steadily decreased in the same period. ... Read more
    #EULAR 2016 – Many Rheumatoid Arthritis Patients Experience Sexual Dysfunction
    June 14, 2016June 14, 2016

    #EULAR 2016 – Many Rheumatoid Arthritis Patients Experience Sexual Dysfunction

    News
    Colombian researchers have found that more than one third of patients with rheumatoid arthritis (RA) who are still sexually active have some type of sexual dysfunction. The results were recently presented ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.